Capital Flow Monitor · Sponsors · CIK 1824224
Bond Biosciences, Inc.
170 English Landing Drive, Parkville, MO, 64152 · 650-804-2139
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$15.0M
Sold
$5.9M
% sold
39.5%
Investors
83
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | D/A ·current | 506(b) | $15.0M | $5.9M | 39.5% | 83 | EDGAR ↗ |
| 2026-04-08 | D | 506(b) | $15.0M | $5.3M | 35.6% | 64 | EDGAR ↗ |
| 2026-01-29 | D/A | 506(b) | $4.5M | $4.5M | 100.0% | 91 | EDGAR ↗ |
| 2025-12-08 | D/A | 506(b) | $4.5M | $4.1M | 90.3% | 84 | EDGAR ↗ |
| 2025-10-22 | D/A | 506(b) | $4.5M | $3.8M | 84.8% | 83 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Michael Beckloff — Director, Parkville, MO
- Cory Berkland — Executive Officer / Director, Parkville, MO
- Timothy Opler — Director, Parkville, MO
- Michael A. Riley — Executive Officer / Director, Parkville, MO
Placement agents
- Collage Venture Partners, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.